Видео ютуба по тегу Ipss-M

6-Molecular prognostic scoring (IPSS-M) – How does it improve patient management?
6-Molecular prognostic scoring (IPSS-M) – How does it improve patient management?
IPSS-R vs IPSS-M for MDS
IPSS-R vs IPSS-M for MDS
Benefits and drawbacks of the IPSS-M
Benefits and drawbacks of the IPSS-M
How the IPSS-M score helps personalizing treatment & combination therapies in HR-MDS
How the IPSS-M score helps personalizing treatment & combination therapies in HR-MDS
Benefits, applicability & uses of the IPSS-M in MDS
Benefits, applicability & uses of the IPSS-M in MDS
Comparing the IPSS-M and IPSS-R for risk stratification of patients with MDS & spliceosome mutations
Comparing the IPSS-M and IPSS-R for risk stratification of patients with MDS & spliceosome mutations
IPSS-M and the Importance of Genetic Mutations testing
IPSS-M and the Importance of Genetic Mutations testing
Elsa Bernard: IPSS-M in MDS | #10 | Trainee Pearls
Elsa Bernard: IPSS-M in MDS | #10 | Trainee Pearls
Evaluating IPSS-R and IPSS-M in patients with HR-MDS enrolled in STIMULUS-MDS1 and STIMULUS-MDS2
Evaluating IPSS-R and IPSS-M in patients with HR-MDS enrolled in STIMULUS-MDS1 and STIMULUS-MDS2
Feasibility of the IPSS-M in CMML
Feasibility of the IPSS-M in CMML
Validation of the IPSS-M risk stratification system in MDS
Validation of the IPSS-M risk stratification system in MDS
IPSS-M: prognostic power in HMA-treated MDS patients
IPSS-M: prognostic power in HMA-treated MDS patients
Real-world validation of the value of the IPSS-M for prognostication in patients with MDS
Real-world validation of the value of the IPSS-M for prognostication in patients with MDS
Updates in MDS diagnosis and prognosis with the IPSS-M: personalized medicine in 2023
Updates in MDS diagnosis and prognosis with the IPSS-M: personalized medicine in 2023
El modelo IPSS-M para SMD: ventajas y usos
El modelo IPSS-M para SMD: ventajas y usos
How Is Molecular Testing Used in MDS Risk Stratification?
How Is Molecular Testing Used in MDS Risk Stratification?
PR: ПОЗИЦИОНИРОВАНИЕ по И.Л. Викентьеву-II
PR: ПОЗИЦИОНИРОВАНИЕ по И.Л. Викентьеву-II
Relevance of the IPSS-R during SCT in patients with MDS in the molecular classification era
Relevance of the IPSS-R during SCT in patients with MDS in the molecular classification era
Is Complete Response Enough? An Expert Look Towards the Future of Higher Risk MDS Treatment
Is Complete Response Enough? An Expert Look Towards the Future of Higher Risk MDS Treatment
IPSSM vs Psychiatre vs Psychologue ?
IPSSM vs Psychiatre vs Psychologue ?